FLS vs. XYL, DOV, SNA, PNR, IEX, GGG, NDSN, SWK, ITT, and LECO
Should you be buying Flowserve stock or one of its competitors? The main competitors of Flowserve include Xylem (XYL), Dover (DOV), Snap-on (SNA), Pentair (PNR), IDEX (IEX), Graco (GGG), Nordson (NDSN), Stanley Black & Decker (SWK), ITT (ITT), and Lincoln Electric (LECO). These companies are all part of the "industrial machinery" industry.
Flowserve vs.
Flowserve (NYSE:FLS) and Xylem (NYSE:XYL) are both industrial products companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, media sentiment, profitability, dividends, community ranking, analyst recommendations and valuation.
Flowserve received 65 more outperform votes than Xylem when rated by MarketBeat users. Likewise, 63.99% of users gave Flowserve an outperform vote while only 63.18% of users gave Xylem an outperform vote.
Xylem has a net margin of 9.85% compared to Flowserve's net margin of 5.90%. Flowserve's return on equity of 17.10% beat Xylem's return on equity.
Xylem has higher revenue and earnings than Flowserve. Flowserve is trading at a lower price-to-earnings ratio than Xylem, indicating that it is currently the more affordable of the two stocks.
In the previous week, Xylem had 7 more articles in the media than Flowserve. MarketBeat recorded 16 mentions for Xylem and 9 mentions for Flowserve. Flowserve's average media sentiment score of 1.41 beat Xylem's score of 1.07 indicating that Flowserve is being referred to more favorably in the media.
93.9% of Flowserve shares are owned by institutional investors. Comparatively, 88.0% of Xylem shares are owned by institutional investors. 0.7% of Flowserve shares are owned by company insiders. Comparatively, 0.3% of Xylem shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Flowserve has a beta of 1.38, suggesting that its share price is 38% more volatile than the S&P 500. Comparatively, Xylem has a beta of 1.05, suggesting that its share price is 5% more volatile than the S&P 500.
Flowserve presently has a consensus target price of $60.10, suggesting a potential upside of 0.35%. Xylem has a consensus target price of $149.64, suggesting a potential upside of 21.81%. Given Xylem's stronger consensus rating and higher possible upside, analysts plainly believe Xylem is more favorable than Flowserve.
Flowserve pays an annual dividend of $0.84 per share and has a dividend yield of 1.4%. Xylem pays an annual dividend of $1.44 per share and has a dividend yield of 1.2%. Flowserve pays out 41.6% of its earnings in the form of a dividend. Xylem pays out 42.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Xylem has increased its dividend for 12 consecutive years. Flowserve is clearly the better dividend stock, given its higher yield and lower payout ratio.
Summary
Xylem beats Flowserve on 11 of the 21 factors compared between the two stocks.
Get Flowserve News Delivered to You Automatically
Sign up to receive the latest news and ratings for FLS and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Flowserve Competitors List
Related Companies and Tools
This page (NYSE:FLS) was last updated on 11/21/2024 by MarketBeat.com Staff